(53 days)
Not Found
Not Found
No
The description focuses on standard spectroscopic data processing and analysis tools, with no mention of AI or ML techniques.
No
The device is described as software for processing and displaying MR spectroscopic data, providing information to support a diagnosis, not to treat a condition.
Yes
The device processes and displays MR spectroscopic data to provide physiological/chemical information that, when interpreted by a trained physician, can be useful in determining a diagnosis. This clearly indicates its role in the diagnostic process.
Yes
The device description explicitly states it is a "package of software tools" and "software applications" designed to operate on existing hardware (GE Signa Horizon Systems and GE Advantage Windows workstations) for processing and displaying MR spectroscopic data. It does not include or require any new hardware components.
Based on the provided information, no, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices intended for use in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information concerning a physiological or pathological state, or a congenital abnormality, or to monitor therapeutic measures.
- SAGE 7's Function: SAGE 7 processes and analyzes MR spectroscopic data. This data is acquired in vivo (from within the living body) using an MR scanner. It is not processing specimens derived from the body in a laboratory setting.
- Intended Use: The intended use describes processing and displaying MR spectroscopic data to provide physiological/chemical information useful in determining a diagnosis. This is based on data acquired directly from the patient, not from a sample taken from the patient.
While the information derived from SAGE 7 is used to support a diagnosis, the device itself operates on data acquired in vivo and does not perform tests on in vitro specimens.
N/A
Intended Use / Indications for Use
SAGE 7 is a package of software tools for MR spectroscopic data processing and display. SAGE 7 is indicated for use for a wide variety of MR spectroscopic data management tasks, including file handling, display, processing/modeling, analysis, storage and hard copy output. The resultant spectroscopic presentations, when interpreted by a trained physician, can provide physiological / chemical information that can be useful in determining a diagnosis.
Product codes (comma separated list FDA assigned to the subject device)
90 LNI
Device Description
The GE SAGE 7 Spectroscopy Analysis Software is designed to operate on GE Signa Horizon Systems and GE Advantage Windows workstations. It provides a toolkit of software applications to handle a wide variety of tasks associated with spectroscopy data management. The SAGE (Spectroscopy Analysis GE) package provides the capability for the trained clinical spectroscopist to reconstruct, analyze, and display spectra and spectroscopic images to provide information to support a diagnosis. SAGE 7 provides a tool for the spectroscopist to process raw spectroscopy data into spectra or spectroscopic images, view them, and optionally perform numerical analyses to obtain spectroscopic parameters (ex. peak positions, widths, heights, areas, etc.).
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MR spectroscopic data
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained clinical spectroscopist, trained physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The SAGE 7 Spectroscopy Analysis option was evaluated to International medical equipment safety standard IEC 601-2-33 titled Particular requirements for the safety of magnetic resonance equipment for medical diagnosis. The SAGE 7 Spectroscopy Analysis option is comparable to the SA/GE Spectroscopy option.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
Image /page/0/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined in a stylized script. The letters are enclosed within a circular border, which has decorative swirls or flourishes around the perimeter. The logo is presented in black and white.
page 1 of 2
P.O. Box 414. W-709 Milwaukee. WI 53201 USA
JAN 1 2 1999
SUMMARY OF SAFETY AND EFFECTIVENESS
- o This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR Part 807.87(h).
- o Identification of Submitter Larry A. Kroger, Ph.D., 414-544-3894, November 19, 1998
- o Identification of the Product SAGE 7 Spectroscopy Analysis Option
| Manufactured by: | GE Medical Systems
3200 N. Grandview Blvd.
Waukesha, WI 53188 |
| ------------------ | --------------------------------------------------------------------- |
|---|
-
0 Marketed Devices
The SAGE 7 Spectroscopy Analysis option is an enhancement to the currently marketed SA/GE Analysis option in distribution since the reclassification of Magnetic Resoncance Diagnostic devices (ref. 53 FR 5078, Feb. 1, 1989). -
Device Description
0
The GE SAGE 7 Spectroscopy Analysis Software is designed to operate on GE Signa Horizon Systems and GE Advantage Windows workstations. It provides a toolkit of software applications to handle a wide variety of tasks associated with spectroscopy data management. The SAGE (Spectroscopy Analysis GE) package provides the capability for the trained clinical spectroscopist to reconstruct, analyze, and display spectra and spectroscopic images to provide information to support a diagnosis. SAGE 7 provides a tool for the spectroscopist to process raw spectroscopy data into spectra or spectroscopic images, view them, and optionally perform numerical analyses to obtain spectroscopic parameters (ex. peak positions, widths, heights, areas, etc.).
1
Image /page/1/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined and enclosed within a circle. The letters and the circle are in black, creating a strong contrast. The logo is a well-known symbol associated with the General Electric company.
page 2 of 2
P.O. Box 414, W-709 Milwaukee, WI 53201 USA
SUMMARY OF SAFETY AND EFFECTIVENESS
o Indications for Use
SAGE 7 is a package of software tools for MR spectroscopic data processing and display. SAGE 7 is indicated for use for a wide variety of MR spectroscopic data management tasks, including file handling, display, processing/modeling, analysis, storage and hard copy output. The resultant spectroscopic presentations, when interpreted by a trained physician, can provide physiological / chemical information that can be useful in determining a diagnosis.
0 Comparison with Predicate
The SAGE 7 Spectroscopy Analysis option is an enhancement to the SA/GE Analysis option. The basic operations (ex. Fourier transform, phasing, peak-picking, integration, fitting, etc.) have not significantly changed, and are provided in both SAGE 7 and the SA/GE Analysis option. What has changed is the sophistication of the user interface. In addition, the increased computational capability of modern workstations have made possible as routine operations some sophisticated curve-fitting algorithms that were impractical on older computer hardware.
o Summary of Studies
The SAGE 7 Spectroscopy Analysis option was evaluated to International medical equipment safety standard IEC 601-2-33 titled Particular requirements for the safety of magnetic resonance equipment for medical diagnosis. The SAGE 7 Spectroscopy Analysis option is comparable to the SA/GE Spectroscopy option.
- 0 Conclusions
It is the opinion of GE that the SAGE 7 Spectroscopy Analysis option is substantially equivalent to the SA/GE Spectroscopy option. SAGE 7 does not include any new indications for use, nor does use of this device result in any new potential hazards.
2
Image /page/2/Picture/0 description: The image shows the text "DEPARTMENT OF HEALTH & HUMAN SERVICES". The text is in all caps and is in a bold, sans-serif font. The text is likely part of a document or sign.
Rockville MD 20850
Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard
JAN 1 2 1999
Larry A. Kroger, Ph.D. Senior Regulatory Programs Manager GE Medical Systems P.O. Box 414 . W-709 Milwaukee, WI 53201
Re: K984167
SAGE 7 Spectroscopy Dated: November 19, 1998 Received: November 20, 1998 Regulatory class: II 21 CFR 892.1000/Procode: 90 LNI
Dear Dr. Kroger:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration,
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for vour device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Capt. Daniel G. Schultz, M.D. Acting Director, Division of Reproductive. Abdominal. Ear. Nose and Throat. and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________
Device Name: SAGE 7 Spectroscopy
Indications For Use:
SAGE 7 is a package of software tools for MR spectroscopic data processing and display. SAGE 7 is indicated for use for a wide variety of MR spectroscopic data management tasks, including file handling, display, processing/modeling, analysis, storage and hard copy output. The resultant spectroscopic presentations, when interpreted by a trained physician, can provide physiological / chemical information that can be useful in determining a diagnosis.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
David A. Seymon
(Division Sign-Off) Division of Reproductive, Abdominal, E and Radiological I 510(k) Number
Prescription Use_ (Per 21 CFR 801.109)
OR
Over-The-Counter Use_